Arabesque Asset Management LTD Eli Lilly & CO Transaction History

Arabesque Asset Management LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $1.39 Million - $1.61 Million	4,310 Added 48.79%	13,143 $4.81 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $1.49 Million - $1.75 Million	-5,333 Reduced 37.65%	8,833 $2.86 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $1.24 Million - $1.54 Million	5,291 Added 59.62%	14,166 $4.06 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $400,682 - $497,249	1,782 Added 25.12%	8,875 $2.45 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $301,154 - $370,612	1,359 Added 23.7%	7,093 $1.64 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $1.04 Million - $1.34 Million	5,734 New	5,734 $1.32 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $2.87 Million - $3.32 Million	-19,644 Closed	0 $0
Q2 2020 Oct 22, 2020	BUY	$136.42 - $164.18 $2.68 Million - $3.23 Million	19,644 New	19,644 $3.23 Million
Q1 2020 Apr 17, 2020	SELL	$119.05 - $147.35 $1.13 Million - $1.4 Million	-9,519 Closed	0 $0
Q4 2019 Jan 30, 2020	SELL	$106.92 - $132.43 $2.45 Million - $3.03 Million	-22,910 Reduced 70.65%	9,519 $1.25 Million
Q3 2019 Oct 25, 2019	BUY	$106.79 - $116.16 $424,169 - $461,387	3,972 Added 13.96%	32,429 $3.63 Million
Q2 2019 Aug 05, 2019	BUY	$110.79 - $129.32 $50,077 - $58,452	452 Added 1.61%	28,457 $3.15 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $104,742 - $123,289	-941 Reduced 3.25%	28,005 $3.63 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $3.07 Million - $3.43 Million	28,946 New	28,946 $3.35 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Arabesque Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Arabesque Asset Management LTD with notifications on news.